Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eyecopharm is a specialized Contract Research Organization (CRO) providing comprehensive preclinical and clinical research services focused exclusively on the field of ophthalmology. Based in Santiago de Compostela, Spain, the company originated as a spin-off from the University of Santiago de Compostela (USC) to bridge the gap between academic research and industrial drug development. Eyecopharm offers a wide range of services including ocular formulation development, pharmacokinetics, toxicology, and regulatory consulting. They utilize advanced animal models and specialized diagnostic tools to support the development of therapies for conditions such as glaucoma, dry eye, and retinal diseases. The company serves a global clientele of pharmaceutical and biotechnology firms seeking expert guidance in ocular drug delivery and efficacy testing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eyecopharm.